RU2002107079A - Вещество, обладающее седативным действием - Google Patents

Вещество, обладающее седативным действием

Info

Publication number
RU2002107079A
RU2002107079A RU2002107079/14A RU2002107079A RU2002107079A RU 2002107079 A RU2002107079 A RU 2002107079A RU 2002107079/14 A RU2002107079/14 A RU 2002107079/14A RU 2002107079 A RU2002107079 A RU 2002107079A RU 2002107079 A RU2002107079 A RU 2002107079A
Authority
RU
Russia
Prior art keywords
sedative
substance
sedative effect
comenic acid
comenic
Prior art date
Application number
RU2002107079/14A
Other languages
English (en)
Other versions
RU2209062C1 (ru
Inventor
Борис Владимирович Крылов
Борис Федорович Щеголев
Original Assignee
Институт физиологии им. И.П. Павлова РАН
Filing date
Publication date
Application filed by Институт физиологии им. И.П. Павлова РАН filed Critical Институт физиологии им. И.П. Павлова РАН
Priority claimed from RU2002107079/14A external-priority patent/RU2209062C1/ru
Priority to RU2002107079/14A priority Critical patent/RU2209062C1/ru
Priority to PCT/US2003/007827 priority patent/WO2003079976A2/en
Priority to US10/389,538 priority patent/US7087640B2/en
Priority to AU2003220260A priority patent/AU2003220260A1/en
Priority to EP03716557.8A priority patent/EP1485050B1/en
Priority to CA002479214A priority patent/CA2479214A1/en
Publication of RU2209062C1 publication Critical patent/RU2209062C1/ru
Application granted granted Critical
Publication of RU2002107079A publication Critical patent/RU2002107079A/ru
Priority to US11/459,659 priority patent/US20060252824A1/en
Priority to US13/225,328 priority patent/US8476314B2/en

Links

Claims (1)

  1. Применение коменовой кислоты в качестве вещества, обладающего седативным действием.
RU2002107079/14A 2002-03-19 2002-03-19 Вещество, обладающее седативным действием RU2209062C1 (ru)

Priority Applications (8)

Application Number Priority Date Filing Date Title
RU2002107079/14A RU2209062C1 (ru) 2002-03-19 2002-03-19 Вещество, обладающее седативным действием
EP03716557.8A EP1485050B1 (en) 2002-03-19 2003-03-14 A substance with sedative effect
US10/389,538 US7087640B2 (en) 2002-03-19 2003-03-14 Substance with sedative effect
AU2003220260A AU2003220260A1 (en) 2002-03-19 2003-03-14 A substance with sedative effect
PCT/US2003/007827 WO2003079976A2 (en) 2002-03-19 2003-03-14 A substance with sedative effect
CA002479214A CA2479214A1 (en) 2002-03-19 2003-03-14 A substance with sedative effect
US11/459,659 US20060252824A1 (en) 2002-03-19 2006-07-25 Substance with sedative effect
US13/225,328 US8476314B2 (en) 2002-03-19 2011-09-02 Substance with sedative effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002107079/14A RU2209062C1 (ru) 2002-03-19 2002-03-19 Вещество, обладающее седативным действием

Publications (2)

Publication Number Publication Date
RU2209062C1 RU2209062C1 (ru) 2003-07-27
RU2002107079A true RU2002107079A (ru) 2003-11-20

Family

ID=28036518

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002107079/14A RU2209062C1 (ru) 2002-03-19 2002-03-19 Вещество, обладающее седативным действием

Country Status (6)

Country Link
US (3) US7087640B2 (ru)
EP (1) EP1485050B1 (ru)
AU (1) AU2003220260A1 (ru)
CA (1) CA2479214A1 (ru)
RU (1) RU2209062C1 (ru)
WO (1) WO2003079976A2 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1641441B1 (en) 2003-04-30 2014-03-12 Purdue Pharma L.P. Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
WO2008038160A2 (en) * 2006-07-25 2008-04-03 Technology Commercialization Corp. A substance with sedative effect for use in the treatment of neurotic disorders
US9283212B2 (en) 2009-02-20 2016-03-15 Palmaya Pty Ltd Pharmaceutical preparation and delivery system
RU2477722C1 (ru) * 2011-07-27 2013-03-20 Государственное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ГОУ ВПО КубГУ) Способ получения литиевой соли коменовой кислоты и применение ее как антиоксидантного стресс- и нейропротекторного средства
RU2514632C1 (ru) * 2012-08-16 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Антиоксидантное, стресс-и нейропротекторное фармакологическое средство-коменат калия
RU2506078C1 (ru) * 2012-08-16 2014-02-10 Федеральное государственное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Антиоксидантное, стресс- и нейропротекторное фармакологическое средство - коменат натрия
RU2561045C1 (ru) * 2014-07-15 2015-08-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Нейропротекторное фармакологическое средство
AU2015306075C1 (en) * 2014-08-18 2021-08-26 Electronic Pain Assessment Technologies (epat) Pty Ltd A pain assessment method and system
CN110592805B (zh) * 2019-08-31 2021-06-15 福建恒安集团有限公司 一种百合夜交藤助眠无纺布的制备方法和应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1796977A (en) * 1931-03-17 Sigkjeents
US1782111A (en) * 1925-08-04 1930-11-18 Naugatuck Chem Co Method of manufacturing tetra-alkylated thiuramdisulphides
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3706831A (en) * 1971-05-14 1972-12-19 Abbott Lab Method for treatment of drug addiction
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US4115567A (en) 1973-12-27 1978-09-19 Carlo Erba S. P. A. 6-Carboxy-2-(2'-pyrazinyl)-chromones and esters thereof
US4115587A (en) * 1976-02-04 1978-09-19 A. H. Robins Company, Inc. Fatty acid amides of norfenfluramine and compositions and methods thereof
US4221723A (en) * 1976-07-19 1980-09-09 Daiichi Seiyaku Company, Ltd. Method of preparing comenic acid
JPS5318739A (en) * 1976-08-03 1978-02-21 Sansho Seiyaku Kk Decolorant for external application
US4124715A (en) * 1977-05-16 1978-11-07 Jose Pozuelo Method of pharmacologically treating drug addiction with fusaric acid
US4117161A (en) * 1977-05-16 1978-09-26 Jose Pozuelo Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine
US4221890A (en) * 1977-09-30 1980-09-09 Thermal-Chem, Inc. Epoxy resin composition and method for making same
US4198426A (en) * 1977-11-28 1980-04-15 Ayerst Mckenna & Harrison Ltd. 2-Substituted-3-methyl-γ-pyrone tricyclic derivatives
US4325952A (en) * 1978-04-18 1982-04-20 Aziende Chimiche Riunite Angelini Francesco Method of treating abstinence syndrome with cycloaklyltriazoles
US4276890A (en) * 1979-04-11 1981-07-07 Fichera Anthony T Tobacco smoking inhibitor
US4311691A (en) * 1979-10-09 1982-01-19 Fichera Anthony T Tobacco smoking inhibitor
EP0107458B1 (en) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
US4696818A (en) * 1984-03-05 1987-09-29 Kim Tuk M Method of treatment during withdrawl from drug dependency
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
US4786653A (en) * 1987-08-24 1988-11-22 Golwyn Daniel H Treatment of neurotransmitter-linked drug abuse
US4788189A (en) * 1988-02-29 1988-11-29 Glazer Howard I Method to treat smoking withdrawal symptoms by potentiated central noradrenergic blocking
US6004951A (en) * 1989-11-22 1999-12-21 Bernstein; Lawrence Richard Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual
US5219858A (en) * 1990-03-27 1993-06-15 Parnell Pharmaceuticals, Inc. Method and compositions for effecting withdrawal from drug dependency
US5646179A (en) * 1991-02-08 1997-07-08 Analyticon Gesellschaft Fur Chemische Analytik Und Consulting Gmbh γ-pyrones, γ-pyridones, and γ-thiopyrones, their use as medicaments and process for preparing same
DE4103904C2 (de) 1991-02-08 1995-06-14 Analyticon Ges Fuer Chemische Neue Arzneimittel aus Gamma-Pyronen, Gamma-Pyridonen sowie Gamma-Thiopyronen
US5866563A (en) * 1991-09-30 1999-02-02 The University Of British Columbia Vanadium compositions
US5298525A (en) * 1992-11-23 1994-03-29 University Technologies International, Inc. Diabetes prevention and treatment
US5411985A (en) * 1993-05-17 1995-05-02 Merck & Co., Inc. Gamma-pyrone-3-acetic acid as an inhibitor or interleukin-1 β inventory enzyme
US5506268A (en) * 1993-06-11 1996-04-09 Nps Pharmaceuticals, Inc. Use of isovaleramide as a mild anxiolytic and sedative agent
US5589182A (en) * 1993-12-06 1996-12-31 Tashiro; Renki Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression
ES2230564T3 (es) * 1995-06-10 2005-05-01 Vitra Pharmaceuticals Ltd. Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds.
GB9521184D0 (en) * 1995-10-17 1995-12-20 Univ Strathclyde Flavonoids
WO1999007413A1 (en) * 1997-08-11 1999-02-18 Algos Pharmaceutical Corporation Substance p inhibitors in combination with nmda-blockers for treating pain
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
TWI324069B (en) * 2000-03-09 2010-05-01 Univ Yale Herbal composition phy906 and its use in chemotherapy
RU2178303C1 (ru) 2000-11-30 2002-01-20 Солагран Лимитед Антиоксидантное и антирадикальное средство

Similar Documents

Publication Publication Date Title
BR0208971B1 (pt) produto absorvente com ajuste melhorado.
BR0208970B1 (pt) produto absorvente com ajuste melhorado.
BR0208969B1 (pt) produto absorvente com ajuste melhorado.
ATE326467T1 (de) Imidazo 1,2-aöpyridine
NO20052975D0 (no) Nye 2',5'-oligoadenylsyreanaloger.
DK1596870T4 (da) Højdosis-ibandronatformulering
RU2002107079A (ru) Вещество, обладающее седативным действием
ATE369342T1 (de) 2,5-disubstituierte 3-mercaptopentansaure
DE60324703D1 (de) Barbitursäure derivaten.
ITMI20032170A1 (it) Tagliacimosse.
RU2003110288A (ru) Вещество, обладающее антидепрессивной активностью
ITRM20020470A0 (it) Lavatoio.
RU2002107007A (ru) Туберкулостатическое средство
ITMI20021328A1 (it) Nuove piperazine 1,4 - disostituite
RU2002131660A (ru) Антидот
RU2002103167A (ru) Кардиопротекторное средство
Whitbourne The Revolution Is Coming: Will Psychology Be Ready?
RU2002117643A (ru) Люплатекс, обладающий противолучевыми свойствами
ES1050939Y (es) Celosia antivandalica.
ES1051950Y (es) Celosia fija.
RU2004132147A (ru) Адаптоген
RU2003103889A (ru) Антигипоксический препарат
ITRA20020023A1 (it) Il mollino.
FI20020644A0 (fi) Kompleksiliuos
ES1051681Y (es) Celosia perfeccionada.